Guidance

Cox-2 selective inhibitors and non-steroidal anti-inflammatory drugs’ (NSAIDs): Cardiovascular safety

Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.

Detail

Medicines and Healthcare products Regulatory Agency guidance for healthcare professionals on the cardiovascular safety of Cox-2 inhibitors and NSAIDs including safety reviews carried out.